av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

23.26

06/11 21:01

Market Cap

2.41B

Beta: 2.11

Volume Today

599.89K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
3.59M
-
5.48M
52.82%
6.79M
23.83%
12.74M
87.78%
9.54M
25.15%
3.57M
62.54%
7.42M
107.61%
4.65M
37.30%
2.36M
49.32%
6.88M
192.02%
7.02M
1.99%
cost of revenue
3.01M
-
gross profit
3.59M
-
5.48M
52.82%
6.79M
23.83%
12.74M
87.78%
9.54M
25.15%
3.57M
62.54%
7.42M
107.61%
4.65M
37.30%
2.36M
49.32%
3.88M
64.40%
7.02M
81.16%
selling and marketing expenses
general and administrative expenses
20.62M
-
33.84M
64.08%
35.98M
6.33%
25.00M
30.51%
19.27M
22.93%
15.43M
19.94%
14.46M
6.29%
20.49M
41.73%
27.20M
32.74%
30.91M
13.68%
38.55M
24.69%
selling general and administrative expenses
20.62M
-
33.84M
64.08%
35.98M
6.33%
25.00M
30.51%
19.27M
22.93%
15.43M
19.94%
14.46M
6.29%
20.49M
41.73%
27.20M
32.74%
30.91M
13.68%
38.55M
24.69%
research and development expenses
104.38M
-
100.17M
4.03%
102.73M
2.55%
96.17M
6.38%
66.45M
30.91%
42.67M
35.78%
42.53M
0.32%
53.31M
25.34%
82.26M
54.30%
115.00M
39.81%
163.55M
42.21%
other expenses
1.01M
-
1.01M
0%
997K
1.58%
896K
10.13%
224K
75%
42.70M
18,964.73%
54.02M
26.48%
55.38M
2.52%
90.34M
63.14%
130.23M
44.16%
cost and expenses
126.02M
-
135.02M
7.15%
139.70M
3.47%
122.07M
12.62%
85.94M
29.60%
58.10M
32.40%
56.99M
1.91%
73.80M
29.49%
109.45M
48.31%
148.93M
36.06%
202.10M
35.70%
operating expenses
126.02M
-
135.02M
7.15%
139.70M
3.47%
122.07M
12.62%
85.94M
29.60%
58.10M
32.40%
56.99M
1.91%
73.80M
29.49%
109.45M
48.31%
145.92M
33.31%
202.10M
38.50%
interest expense
15.97M
-
151.09M
845.97%
-2.91M
-
ebitda
-121.42M
-
-130.87M
7.79%
-136.31M
4.15%
-96.03M
29.55%
-635K
99.34%
-58.17M
9,060.94%
-38.20M
34.34%
-67.56M
76.87%
-101.87M
50.78%
-139.03M
36.49%
-191.90M
38.02%
operating income
-122.43M
-
-129.54M
5.81%
-132.92M
2.61%
-121.53M
8.57%
-156.44M
28.73%
-55.03M
64.82%
-63.35M
15.12%
-71.24M
12.45%
-115.23M
61.75%
-142.04M
23.26%
-195.08M
37.34%
depreciation and amortization
1.01M
-
1.01M
0%
997K
1.58%
5.31M
432.60%
224K
95.78%
-3.14M
1,502.23%
25.16M
900.92%
3.69M
85.35%
13.37M
262.74%
3.01M
77.50%
3.18M
5.62%
total other income expenses net
4.35M
-
2.34M
46.11%
4.39M
87.12%
-7.99M
282.08%
-75.55M
845.97%
4.15M
105.50%
2.41M
42.04%
505K
79.02%
2.91M
476.04%
613K
78.93%
37.22M
5,970.96%
income before tax
-118.08M
-
-127.20M
7.72%
-128.53M
1.05%
-117.31M
8.73%
-151.95M
29.52%
-50.88M
66.52%
-60.95M
19.79%
-70.74M
16.06%
-112.33M
58.79%
-141.43M
25.91%
-157.86M
11.62%
income tax expense
-4.35M
-
-2.34M
46.11%
-8.77M
274.23%
-24.28M
176.81%
-765K
96.85%
-506K
33.86%
-1.17M
130.63%
-227K
80.55%
10.46M
4,707.05%
net income
-118.08M
-
-127.20M
7.72%
-128.53M
1.05%
-93.03M
27.62%
-151.18M
62.51%
-50.37M
66.68%
-59.78M
18.68%
-70.51M
17.95%
-122.78M
74.13%
-141.43M
15.19%
-157.86M
11.62%
weighted average shs out
5.96M
-
6.47M
8.56%
6.77M
4.61%
8.57M
26.61%
10.44M
21.84%
14.51M
38.93%
29.64M
104.32%
42.87M
44.64%
46.89M
9.37%
48.45M
3.33%
64.39M
32.91%
weighted average shs out dil
5.96M
-
6.47M
8.56%
6.77M
4.61%
8.57M
26.61%
10.44M
21.84%
14.51M
38.93%
29.64M
104.32%
42.87M
44.64%
46.89M
9.37%
48.45M
3.33%
64.39M
32.91%
eps
-19.81
-
-19.66
0.76%
-18.99
3.41%
-10.86
42.81%
-14.48
33.33%
-3.47
76.04%
-2.02
41.79%
-1.64
18.81%
-2.62
59.76%
-2.92
11.45%
-2.45
16.10%
epsdiluted
-19.81
-
-19.66
0.76%
-18.99
3.41%
-10.86
42.81%
-14.48
33.33%
-3.47
76.04%
-2.02
41.79%
-1.64
18.81%
-2.62
59.76%
-2.92
11.45%
-2.45
16.10%

All numbers in USD (except ratios and percentages)